- Primary & Secondary Syphilis
Syphilis Testing Market is estimated to be valued at USD 1,538.4 Million in 2023 and is poised to grow at a significant CAGR of 8.5% over 2023-2029. Syphilis is a sexually transmitted disease caused by Treponema pallidum bacteria. Syphilis tests are used for screening and detection of antibodies against bacteria into the patients’ blood. There are various complications related to syphilis infection, such as infertility in both, men and women, ectopic pregnancy, cervical cancer in women and congenital mortality, and infections. The Primary segment anticipated to grow at significant CAGR over the forecast years. The first stage happens two to 12 weeks after exposure to the bacteria. During this stage, a smooth, red sore called a chancre develops on the genitals or in the mouth. It goes away on its own in a few weeks or months. A chancre is small and usually painless, so you may not even know it’s there. Blood tests can confirm the presence of antibodies that the body produces to fight infection. The antibodies to the syphilis-causing bacteria remain in your body for years, so the test can be used to determine a current or past infection which can anticipated the growth of syphilis testing market. Rising public awareness about syphilis treatment, increase in the occurrence of sexually transmitted disease, increasing government funding or investments on STD testing, Impact of social taboos and stigmas are a few factors driving the industry's growth over the forecasting period.
Syphilis Testing Market Key Developments:
In July 2019, the startup launched three new test kits, which will test for conditions such as chlamydia, gonorrhea, and syphilis.
Fastest Growing Market
The market for syphilis testing is expanding because of rising rates of sexual interaction, higher prevalence of STDs, and technological breakthroughs in syphilis testing. Additionally, the global increase in the elderly population spurs market expansion. Lack of health insurance and little consumer awareness of the advantages of tests restrain market expansion. Higher adoption rates for technologically advanced screening tests, active measures from the governments and private associations, and growing awareness for the syphilis infections largely contribute to the growth of the market.
2022 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.